Medicalsystem Biotechnology Co., Ltd. (300439.SZ)
CNY 10.93
(1.3%)
CNY 10.93
(1.3%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 259.01 Million CNY | 18.79% |
| 2022 | 218.03 Million CNY | 3.14% |
| 2021 | 211.38 Million CNY | -16.75% |
| 2020 | 253.91 Million CNY | -38.0% |
| 2019 | 409.52 Million CNY | 5.43% |
| 2018 | 388.41 Million CNY | -12.27% |
| 2017 | 442.74 Million CNY | 32.02% |
| 2016 | 335.35 Million CNY | 194.65% |
| 2015 | 113.81 Million CNY | 48.66% |
| 2014 | 76.56 Million CNY | 48.09% |
| 2013 | 51.69 Million CNY | 13.15% |
| 2012 | 45.68 Million CNY | 125.63% |
| 2011 | 20.24 Million CNY | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 234.75 Million CNY | -9.36% |
| 2024 Q3 | 262.04 Million CNY | 5.3% |
| 2024 Q2 | 248.84 Million CNY | 6.0% |
| 2023 Q3 | 221.85 Million CNY | 6.54% |
| 2023 FY | 259.01 Million CNY | 18.79% |
| 2023 Q1 | 210.69 Million CNY | -3.36% |
| 2023 Q2 | 208.23 Million CNY | -1.17% |
| 2023 Q4 | 259.01 Million CNY | 16.75% |
| 2022 Q4 | 218.03 Million CNY | -5.35% |
| 2022 FY | 218.03 Million CNY | 3.14% |
| 2022 Q2 | 230.1 Million CNY | -8.14% |
| 2022 Q1 | 250.49 Million CNY | 18.5% |
| 2022 Q3 | 230.36 Million CNY | 0.11% |
| 2021 Q3 | 223.78 Million CNY | 2.43% |
| 2021 Q2 | 218.47 Million CNY | -12.87% |
| 2021 Q1 | 250.74 Million CNY | -1.25% |
| 2021 FY | 211.38 Million CNY | -16.75% |
| 2021 Q4 | 211.38 Million CNY | -5.54% |
| 2020 FY | 253.91 Million CNY | -38.0% |
| 2020 Q4 | 253.91 Million CNY | -21.1% |
| 2020 Q3 | 321.83 Million CNY | -2.95% |
| 2020 Q2 | 331.6 Million CNY | -15.9% |
| 2020 Q1 | 394.31 Million CNY | -3.71% |
| 2019 Q2 | 417.55 Million CNY | -4.56% |
| 2019 Q1 | 437.51 Million CNY | 12.64% |
| 2019 FY | 409.52 Million CNY | 5.43% |
| 2019 Q4 | 409.52 Million CNY | -2.25% |
| 2019 Q3 | 418.96 Million CNY | 0.34% |
| 2018 Q2 | 445.14 Million CNY | 10.25% |
| 2018 Q1 | 403.77 Million CNY | -8.8% |
| 2018 FY | 388.41 Million CNY | -12.27% |
| 2018 Q4 | 388.41 Million CNY | -13.66% |
| 2018 Q3 | 449.88 Million CNY | 1.07% |
| 2017 FY | 442.74 Million CNY | 32.02% |
| 2017 Q1 | 300.71 Million CNY | -10.33% |
| 2017 Q4 | 442.74 Million CNY | 2.92% |
| 2017 Q3 | 430.16 Million CNY | 15.94% |
| 2017 Q2 | 371.03 Million CNY | 23.38% |
| 2016 Q2 | 164 Million CNY | 31.09% |
| 2016 Q4 | 335.35 Million CNY | 67.95% |
| 2016 Q3 | 199.67 Million CNY | 21.75% |
| 2016 Q1 | 125.1 Million CNY | 9.92% |
| 2016 FY | 335.35 Million CNY | 194.65% |
| 2015 Q2 | 101.23 Million CNY | 27.35% |
| 2015 Q3 | 118.42 Million CNY | 16.98% |
| 2015 Q1 | 79.49 Million CNY | 3.83% |
| 2015 FY | 113.81 Million CNY | 48.66% |
| 2015 Q4 | 113.81 Million CNY | -3.89% |
| 2014 Q4 | 76.56 Million CNY | -13.73% |
| 2014 Q1 | - CNY | 0.0% |
| 2014 FY | 76.56 Million CNY | 48.09% |
| 2014 Q3 | 88.74 Million CNY | 0.0% |
| 2013 FY | 51.69 Million CNY | 13.15% |
| 2012 FY | 45.68 Million CNY | 125.63% |
| 2011 FY | 20.24 Million CNY | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Dian Diagnostics Group Co.,Ltd. | 1.5 Billion CNY | 82.835% |
| Hangzhou Tigermed Consulting Co., Ltd. | 23.39 Million CNY | -1006.991% |
| Dirui Industrial Co.,Ltd. | 572.93 Million CNY | 54.792% |
| Beijing Strong Biotechnologies, Inc. | 229.74 Million CNY | -12.738% |
| Maccura Biotechnology Co.Ltd | 907.48 Million CNY | 71.459% |
| Guangzhou Wondfo Biotech Co.,Ltd | 351.4 Million CNY | 26.292% |
| Guangdong Hybribio Biotech Co.,Ltd. | 99.55 Million CNY | -160.16% |
| BGI Genomics Co., Ltd. | 602.18 Million CNY | 56.988% |
| Amoy Diagnostics Co., Ltd. | 28.78 Million CNY | -799.883% |
| Shanghai Labway Clinical Laboratory Co., Ltd. | 367.71 Million CNY | 29.561% |